Immune Response News and Research

RSS

Allergic rhinitis linked to the development of Parkinson's disease

Researchers from Mayo Clinic have discovered that allergic rhinitis is associated with the development of Parkinson's disease later in life. Findings will be published in the Aug. 8 issue of the journal Neurology.

7 Aug 2006

Role of peptidoglycan protein in immune response may aid HIV research

A family of proteins that serve as the body's first line of defense against bacterial infections may provide a lifeline for individuals with compromised immune systems.

6 Aug 2006

HIV virus can survive efforts to destroy it by hiding in the mucosal tissues of the intestine

UC Davis researchers have discovered that the human immunodeficiency virus, the virus that causes AIDS, is able to survive efforts to destroy it by hiding out in the mucosal tissues of the intestine.

6 Aug 2006

Interleukin 21 may enhance the effectiveness of Herceptin

Preliminary research suggests that a drug that targets a particular type of breast cancer might be more effective if patients are also given a substance made by the body that stimulates certain immune cells.

6 Aug 2006

Turning the immune system against cancer

Medicine can now prevent a host of diseases with a mere shot of vaccine. Polio and smallpox are almost non-existent, and mumps and chicken pox are rarely seen nowadays.

4 Aug 2006

Methamphetamine increases production of protein that promotes the spread of the HIV-1 virus in infected drug users

Researchers at the University at Buffalo have presented the first evidence that the addictive drug methamphetamine, or meth, also commonly known as "speed" or "crystal," increases production of a docking protein that promotes the spread of the HIV-1 virus in infected users.

4 Aug 2006

Stopping antiretroviral therapy in HIV-infected patients could be beneficial

Stopping antiretroviral therapy in HIV-infected patients from time to time could reduce the side effects and costs of the treatment, according to a study in this week's issue of The Lancet.

3 Aug 2006

Longer needles best for infant immunisation

Infants vaccinated with a long needle experience fewer reactions but get the same protection (immunogenicity) as a shorter needle, finds a study published on bmj.com today.

3 Aug 2006

Genomic expansion and diversification in a African sleeping sickness parasite allow it to evade host detection

A team of scientists headed by Dr. Sara Melville at the University of Cambridge has shown that the parasite known to cause African sleeping sickness has evolved an unusual chromosomal structure as a result of environmental adaptation.

3 Aug 2006

Better understanding of intravenous immunoglobulin

For years, researchers have struggled to understand how IVIG worked. It's ability to treat autoimmune diseases seemed to bean apparent contradiction.

3 Aug 2006

Protein CD86 raises antibody output

Cancer immunologists here have discovered how a protein on the surface of antibody-making immune cells boosts the amount of antibody the cells make.

2 Aug 2006

Innovative approach for creating a cytomegalovirus vaccine

Each year, about 40,000 children are born infected with human cytomegalovirus, or CMV, and about 8,000 of these children suffer permanent disabilities due to the virus - almost one an hour.

2 Aug 2006

Anti-obesity vaccine keeps rats trim

Researchers at the Scripps Research Institute in California in the U.S. have developed an anti-obesity vaccine that significantly slowed weight gain and reduced body fat in rats even when they over ate.

1 Aug 2006

Future looks bleak for victims of 'elephant man' drug trial

The men who suffered horrendous reactions during a drug trial in the UK could well be facing developing cancer and other fatal diseases as a result of being poisoned in the test, and are at risk of an early death.

31 Jul 2006

New bird flu vaccine has 80% protection rate

According to the manufacturer the latest bird flu vaccine is more than 80% effective in protecting people against the virus.

26 Jul 2006

Vaccination with irradiated Listeria induced protective T cell immunity

Vaccines made with bacteria killed by gamma irradiation, rather than by standard methods of heat or chemical inactivation, may be more effective, say researchers.

26 Jul 2006

Using gamma radiation preserves T-cell responses in bacterial vaccine

Using gamma radiation to inactivate bacteria for the preparation of vaccines, instead of traditional heat or chemical methods of inactivation, appears to create a vaccine that is more effective than so-called "killed" vaccines against disease, and has the added advantage of a longer storage life than "live" vaccines.

26 Jul 2006